Intelligent Volume Assured Pressure Support to Improve Sleep Quality and Respiratory Events in Patients With Non Invasive Ventilation

Overview

Aim of this prospective randomized trial is to compare non invasive ventilation (NIV) with pressure control (BiPAP-ST) to volume assured pressure support (iVAPS) with regards to sleep quality and alveolar ventilation in patients with routine NIV initiation after COPD exacerbation. 20 patients with COPD and chronic hypercapnic respiratory failure will spent two nights on NIV, one with spontaneous timed pressure controlled bilevel ventilation (BiPAP-ST) and one with the advanced mode of intelligent volume assured pressure support (iVAPS). Patients will spend the treatment nights in randomized order under polysomnographic surveillance, including transcutaneous PCO2 measurement. Besides the number of arousals and PCO2 values over night the sleep quality will be judged with regards to especially adjusted respiratory event criteria like unintentional leaks, patient ventilator asynchrony, and decrease of ventilatory drive.

Full Title of Study: “German: Einfluss Von Gesichertem Atemminutenvolumen Auf Schlafqualität Und Häufigkeit Respiratorischer Ereignisse Bei Patienten Mit Nicht Invasiver Beatmung (NIV)”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: May 2014

Detailed Description

Non invasive ventilation (NIV) is one of the major medical innovations of the last 30 years. Especially continuous positive airway pressure (CPAP) is the established Gold Standard in obstructive sleep apnea (OSA) treatment. NIV with bilevel ventilation (BiPAP-ST) is the established Gold Standard in acute hypercapnic respiratory failure, especially in exacerbated COPD. Still, the adaption of CPAP in OSA is less complicated than a bilevel therapy in hypercapnic failure. The adjustment of NIV requires not only the definition of expiration pressure (PEEP) but also of inspiration pressure support. Only adequate pressure difference guarantees effective ventilatory assistance and an improvement of alveolar ventilation. The pressure changes need to be defined by the physician, as well as the breathing frequency. Ventilation can furthermore be controlled by a target volume (volume controlled) or a target pressure (pressure controlled). Moreover, patients with respiratory insufficiency are often suffering of significant dyspnoea and are hard to accustom to a respiratory mask. There is a lack of systematic studies addressing the effects of different ventilator settings on sleep and life quality, as well as studies about the necessary monitoring extent during the NIV initiation.

Interventions

  • Device: pressure controlled ventilation BIPAP ST
    • spontaneous timed pressure controled bilevel ventilation
  • Device: volume assured pressure support IVAPS
    • intelligent volume assured Pressure Support
  • Device: NIV
    • Patients with COPD and chronic hypercapnic respiratory failure will spent two nights on NIV, one with spontaneous timed pressure controlled bilevel ventilation (BiPAP ST) and one with the advanced mode of intelligent volume assured pressure support (IVAPS). Patients will spend the treatment nights in randomized order under polysomnographic surveillance, including transcutaneous PCO2 measurement.

Arms, Groups and Cohorts

  • Active Comparator: BIPAP ST
    • one night, NIV with pressure controlled ventilation (BIPAP ST) with individually titrated pressure parameters.
  • Experimental: IVAPS
    • one night, NIV with volume assured pressure support (IVAPS).The pressure parameters will be adjusted according to the BIPAP pressure levels.

Clinical Trial Outcome Measures

Primary Measures

  • Number of respiratory events during non invasive ventilation
    • Time Frame: 2 nights
    • Unintentional leak, patient ventilator asynchrony, decrease of ventilatory drive, Apnoea, Hypopnea

Secondary Measures

  • Sleep efficiency
    • Time Frame: 2 nights
    • Relation between “time in bed” and “total sleep time” measured by a polysomnography under non invasive ventilation.

Participating in This Clinical Trial

Inclusion Criteria

  • Stable respiratory insufficiency – Hypercapnia >50 mmHG – Clinically required NIV – Capable of giving consent Exclusion Criteria:

  • Existing ventilatory support – Invasive ventilation – Any other severe physical disease that requires immediate medical assistance – Acute hypercapnic decompensation with pH <7.30 in routine BGA – Circumstances that doesn't allow mask ventilation (e.g. facial deformation) – Participation in a clinical trial within the last 4 weeks – Pregnancy or nursing period – Drug addiction

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: 75 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Institut für Pneumologie Hagen Ambrock eV
  • Collaborator
    • ResMed
  • Provider of Information About this Clinical Study
    • Principal Investigator: Georg Nilius, PD Dr. med. – Helios Klinik Ambrock
  • Overall Official(s)
    • Georg Nilius, MD, Principal Investigator, Helios Klinik Hagen

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.